A lawsuit has been filed alleging that dupixent injections caused a diagnosis of peripheral t-cell lymphoma. The lawsuit claims the manufacturer failed to warn about the risk of t-cell lymphoma, a type of cancer, as a potential side effect of the injections. There are also reports of lawsuits related to cutaneous t-cell lymphoma diagnoses, although it is unclear if these are separate or related claims.